Everand Logo

Welcome to Everand!

  • STAT

    STAT Plus: Pharmalittle: Thousands sign up for trials studying hydroxycholoroquine; Gilead drug fails to help Covid-19 patients

    Thousands of Covid-19 patients worldwide are signing up for studies exploring whether antimalaria drugs fight off infections of the novel coronavirus.
    by Ed Silverman Apr 24, 2020 1 minute
    Source: Alex Hogan/STAT

    And so, another working week will soon draw to a close. This may be hard to tell for those of you

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
    An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
    MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Sanofi Licensing Novavax’s Covid Shot, Moderna’s RSV Vaccine, And More
    Sanofi said it has reached a licensing deal to sell Novavax’s Covid shot as well as to try to combine the vaccine with Sanofi’s own flu vaccine.

    Related Books & Audiobooks